Good news about the discovery of a vaccine to covid19.

Good news about the discovery of a vaccine to covid 19
. The two international drug companies, Pfizer and Biotank, said that a new vaccine was invented for the emerging corona virus .. This vaccine has been tested on approximately 43,654 from 6 different countries and has proven its efficiency exceeding 90%

How the new vaccine works

Part of the genetic code of the virus is taken and then it gives instructions to the cells about what they should build, as they encapsulate them with fat so that they can enter the cells of the body.

The vaccine will be given in two doses, about 3 weeks apart

And trials in Germany, Turkey, the United States and Iran showed that those who received the vaccine gained 90 percent immunity seven days after they received the second dose.

Pfizer said it could produce nearly 50 million doses by the end of this year and produce nearly 1.4 billion doses by the end of 2021.

The new vaccine needs to be kept at a temperature of -80 below zero

But some other information about the vaccine was not available, such as how long the immunity of the person receiving the vaccine lasts against Corona virus
The vaccine-producing companies stated that most of the information needed about the new vaccine will be cleared by the end of the third week of this month, which will allow the new drug to be used internationally.

According to the statements of many medical professors around the world, it is a defining moment, even though it is the beginning of the journey.

New to Corona Virus

Insulin pump

An insulin pump is a substitute for multiple daily injections
  Insulin pumps are used to continuously deliver insulin to a person with type 1 diabetes.
Its most important feature is the continuous delivery of insulin to the blood throughout the day according to blood glucose levels without the need for continuous measurement of the level of sugar and without resorting to stinging several times

  Accurate delivery of very small doses is useful for infants and children. It has also been noted that children who use the pump reduce the incidence of ketosis and coma by up to 90%.

  Contributes to reducing the occurrence of long-term complications such as peripheral neuropathy and vascular inflammatory injury that causes diabetic foot and visual impairment
  In an insulin pump we replace slow-acting insulin to meet basic needs with continuous infusion of rapid-acting insulin.

  An insulin pump provides one type of fast-acting insulin in two ways:

  A dose pumped out to cover the food eaten or to correct a high blood sugar level.

  A base dose that is continuously pumped at an adjustable base rate to deliver the required insulin between meals and at night.

  Users reported better quality of life compared to using other insulin administration devices.  Improvement has been reported in type 1 and type 2 diabetes requiring insulin therapy

  Using fast-acting insulin to meet basic needs provides relative freedom from the structured meals and exercise regimen that was previously necessary to control blood sugar with slow-acting insulin.

  Programmable basal modifiers allow the scheduled delivery of insulin in different amounts at different times of the day.  This is especially helpful in controlling events such as the dawn phenomenon that leads to low blood sugar during the night.

  Many users feel that taking insulin from the pump is more convenient and discreet than an injection
Insulin pumps also make it possible to deliver more accurate amounts of insulin than can be injected with a syringe.  This supports tighter control of blood sugar and glycated hemoglobin (HGBA1C) levels, which reduces the chance of long-term complications associated with diabetes.  This is expected to result in long-term cost savings compared to multiple daily injections.

  Many modern “smart” pumps have a “processor” that calculates the amount of insulin you need taking into account the amount of expected carbohydrates, blood sugar level and active insulin.

  Insulin pumps can provide an accurate record of insulin use with their history lists.  On many insulin pumps, this log can be downloaded to a computer and graphed for trend analysis.

  Neuropathy is an unpleasant complication of diabetes resistant to usual treatment.  There are reports of amelioration or complete disappearance of neuropathic pain with insulin pumps.

  Numerous studies have shown that patients who use an insulin pump enjoy greater freedom in eating meals and enjoy good sexual health as chronic high sugar negatively affects sexual health .. The pump adjusts sugar levels, allowing the side effects to fade in the long run
Insulin pumps, cartridges, and infusers may be much more expensive than syringes used to inject insulin with many insulin pumps costing more than $ 12,000.  Another disadvantage of using it is the necessity to follow up the battery that continues to work for a continuous month without the need to charge and the device has a battery indicator and an insulin tank indicator.

  An insulin pump user can influence the fast-acting insulin profile through dose formation.  Users can experiment with dosage forms to determine what works best for any given food, which means they can improve blood sugar control by adapting the dosage form to their needs.

There are two types of fixed doses for pump users
The first dose is the basic dose that is given to the patient before eating, in order to fade the sudden rise in sugar after eating high-sugar meals, and the basic dose is determined according to the type of food, the patient’s weight, and the amount of the meal he eats each time.
The second is the extended dose is a slow infusion of insulin that spreads over time.  By pumping in a “square wave” form, the dose avoids a high initial dose of insulin that may enter the blood and cause low blood sugar before digestion can facilitate the entry of sugar into the blood.  The extended dose also extends the effect of insulin beyond insulin alone.  An extended dose is appropriate when covering high-fat, protein-rich meals such as steak, which will raise blood sugar for several hours after starting a dose.  An extended dose is also beneficial for those with slow digestion.

  Timing of the dose

  Since the pump user is responsible for starting the dose manually, this provides an opportunity for the user to take a pre-dose to improve the insulin pump’s ability to prevent post-meal hyperglycemia.  A pre-meal dose is just a dose of insulin given before it is actually necessary to cover the carbohydrates eaten.

  Determine the base rate

  Basal insulin requirements vary with different individuals and during the periods of the day.  The basal rate for a certain period of time is determined by fasting with periodic assessment of the blood glucose level.  Do not take food or insulin shots for 4 hours before or during the evaluation period.  If the blood sugar level changes dramatically during the evaluation, the basal rate can be adjusted to increase or decrease insulin delivery to keep the blood sugar level roughly constant.

  For example, to determine basic morning requirements, an individual must skip breakfast.  Upon waking up, they will periodically test your blood glucose level until lunch.  Changes in blood glucose levels are compensated for by adjustments in the morning basal rate.  The process is repeated over several days, with changing the fasting period, until a basic 24-hour profile is formed that keeps blood sugar levels relatively constant.  Once the basal rate of need for basic insulin for fasting is matched, the pump user will then gain the flexibility to skip or postpone meals such as sleeping late on the weekends or overtime on weekdays.

  The pump user should be educated by a diabetic care professional about setting a basal rate before starting treatment with the pump.

  Temporary rates

  Since basal insulin is provided as a fast-acting insulin, basal insulin can be increased or decreased immediately as needed at a temporary basal rate.  Examples when this can be helpful include:

  As a passenger during a long car trip, when more insulin is needed due to inactivity.

  While driving on a long trip, to reduce the risk of hypoglycemia, a temporarily lower base rate can be programmed.

  During and after spontaneous exercise or sports, when the body needs less insulin.

  During illness or stress, when the primary demand increases due to insulin resistance.

  When blood ketones are present, when additional insulin is required.

  When you are on a long fast (such as Ramadan or Lent) when the basic requirements are less.

  During menstruation, when additional basal insulin is needed

ولمعرفة كيفية استخدام مضخة الانسولين واراء اساتذة امراض السكر واراء المختصين في مضخة الانسولين من خلال الروابط التاليةhttps://www.youtube.com/embed/U1X05rBfhEA?feature=oembedhttps://www.youtube.com/embed/7dJQ3vQeDzo?feature=oembed

وهذا احد اشهر المواقع الموثوقة عالميا التي يمكنكم الحصول منها علي جهاز مضخة الانسولين الامريكيةالاحدث عالميا

https://digital-pancreas.com/?key=3d09fafa8af0f1a69b5c917f919fa42cc4af814ef9944796cc590310a8c6c9c3

انباء سارة للجنس البشري عن اكتشاف لقاح جديد لفيرس كورونا المستجد

صرحت شركتا الدواء العالميتان فايزر وبيوتنك انه تم اختراع لقاح جديد لفيرس كورونا المستجد ..هذا اللقاح تم تجربته علي ما يقارب 43654 من 6 دول مختلفه واثبت كفائه تتخطي ال 90٪

كيفية عمل اللقاح الجديد


يتم اخذ جزءا من الشيفرة الجينية للفيروس ومن ثم  تعطي تعليمات للخلايا عما يتوجب عليها بناؤه، حيث تقوم بتغليفها  بالدهون كي تتمكن من دخول خلايا الجسم.

سوف يتم اخذ اللقاح علي جرعتين تفصل بينهما مده حوللي 3 اسابيع

وأظهرت التجارب في كل المانيا وتركيا والولايات المتحده وايران  أن الذين حصلوا على اللقاح اكتسبوا مناعة بنسبة 90 في المئة بعد سبعة أيام من حصولهم على الجرعة الثانية.

وصرحت شركة فايزر انه يمكنها انتاج ما يقارب 50 مليون جرعه بنهاية هذا العام وانتاج ما يقارب 1.4 مليار جرعه بنهاية عام 2021

يحتاج اللقاح الجديد الي الحفظ في درجة حرارة تصل الي -80 تحت الصفر

لكن لم تتوفر بعض المعلومات الاخري عن اللقاح مثل المده التي تدوم معها مناعة الشخص المتلقي للقاح ضد فيرس كورونا
وصرحت الشركات المنتجه للقاح ان اغلبية المعلومات اللازمه عن اللقاح الجديد ستضح بنهاية الاسبوع الثالث من شهر نوفمبر الجاري مما سيسمح باستخدام الدواء الجديد عالميا ..

ووفقا لتصريحات العديد من اساتذة الطب حول العالم فانها لحظة فارقه رغم انها بدية المشوار .